EPLPX
Price
$22.61
Change
+$0.09 (+0.40%)
Updated
Jul 25 closing price
Net Assets
1.1B
RMFEX
Price
$60.79
Change
+$0.27 (+0.45%)
Updated
Jul 25 closing price
Net Assets
110.54B
Interact to see
Advertisement

EPLPX vs RMFEX

Header iconEPLPX vs RMFEX Comparison
Open Charts EPLPX vs RMFEXBanner chart's image
NYLI Epoch U.S. Equity Yield
Price$22.61
Change+$0.09 (+0.40%)
VolumeN/A
Net Assets1.1B
American Funds American Mutual R4
Price$60.79
Change+$0.27 (+0.45%)
VolumeN/A
Net Assets110.54B
EPLPX vs RMFEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EPLPX vs. RMFEX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EPLPX is a Buy and RMFEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFEX has more cash in the bank: 111B vs. EPLPX (1.1B). EPLPX pays higher dividends than RMFEX: EPLPX (2.07) vs RMFEX (1.53). EPLPX was incepted earlier than RMFEX: EPLPX (16 years) vs RMFEX (23 years). EPLPX (1.05) is less costly to investors than RMFEX (0.62). RMFEX is a more actively managed with annual turnover of: 31.00 vs. EPLPX (13.00). RMFEX has a lower initial minimum investment than EPLPX: RMFEX (250) vs EPLPX (15000). RMFEX annual gain was more profitable for investors over the last year : 11.74 vs. EPLPX (5.44). EPLPX (64.33) and RMFEX (62.99) have equivalent 5 years return.
EPLPXRMFEXEPLPX / RMFEX
Total Expense Ratio1.050.62169%
Annual Report Gross Expense Ratio1.050.62169%
Fund Existence16 years23 years-
Gain YTD8.54611.52774%
Front Load6%N/A-
Min. Initial Investment150002506,000%
Min. Initial Investment IRAN/AN/A-
Net Assets1.1B111B1%
Annual Yield % from dividends2.071.53135%
Returns for 1 year5.4411.7446%
Returns for 3 years28.4732.0889%
Returns for 5 years64.3362.99102%
Returns for 10 years83.9888.9694%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BEAM21.720.77
+3.68%
Beam Therapeutics
ESPR1.510.02
+1.34%
Esperion Therapeutics
BMRN59.01-0.75
-1.26%
BioMarin Pharmaceutical
TOUR0.86-0.02
-2.16%
Tuniu Corp
IMTE1.15-0.11
-8.73%
Integrated Media Technology Limited